| |
|
You are searching for "CFAMM00033783" in compound.
Total 1 results found.
Click on CFAM IDs and names to search or view in CFAM, click on external IDs to view the entity in its source database.
| CFAM Mol ID | CFAMM00033783 |
| Family | CFFAD188 D(2) dopamine receptor Ligand Nemonapride Family |
| Superfamily | CFSAD176 D(2) dopamine receptor Ligand Nemonapride Superfamily |
| Class | CFCAD171 Class 171 |
| External ID | CHEMBL372479 |
External Source | CHEMBL |
| PubChem CID |
11693471 |
Functional Category |
Bioactive |
| Molecule Name |
AGN-PC-00E9H2 |
| IUPAC Name |
2-[4-[[[5-[[1-[2-(4-amino-5-chloro-2-methoxybenzoyl)oxyethyl]piperidin-4-yl]methylamino]-5-oxopentanoyl]amino]methyl]piperidin-1-yl]ethyl 4-amino-5-chloro-2-methoxybenzoate |
| Synonyms |
CHEBI:431347;2-[4-[[[5-[[1-[2-(4-amino-5-chloro-2-methoxybenzoyl)oxyethyl]piperidin-4-yl]methylamino]-5-oxopentanoyl]amino]methyl]piperidin-1-yl]ethyl 4-amino-5-chloro-2-methoxybenzoate |
| InChi |
InChI=1S/C37H52Cl2N6O8/c1-50-32-20-30(40)28(38)18-26(32)36(48)52-16-14-44-10-6-24(7-11-44)22-42-34(46)4-3-5-35(47)43-23-25-8-12-45(13-9-25)15-17-53-37(49)27-19-29(39)31(41)21-33(27)51-2/h18-21,24-25H,3-17,22-23,40-41H2,1-2H3,(H,42,46)(H,43,47) |
| InChiKey |
DSNSUQBBIJVZKB-UHFFFAOYSA-N |
| Formula | C37H52Cl2N6O8 |
Molecular Weight | 779.75 |
| Cross Link | CHEMBL372479 |
| Structure |
|
Statistics of CFAM Database |
CFAM currently contains 490,279 molecules in 87,136 families, 34,880 superfamilies and 11,643 classes.
|
How to cite our database |
|
C. Zhang, L. Tao, C. Qin, P. Zhang, S.Y. Chen, X. Zeng, F. Xu, Z. Chen, S.Y. Yang and Y.Z. CFam: A Chemical Families Database Based on Iterative Selection of Functional Seeds and Seed-Directed Compound Clustering.
Nucl. Acids Res. 43 (D1): D558-D565 (2015) (First published online: November 20, 2014).
|
Last update by |
|
2014.08.29
|
27398 visits since 2014 .........
Dr.
Chen Yuzong
Deputy
Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
